Annual report pursuant to Section 13 and 15(d)

Prepaid Expenses and Other Current Assets (Tables)

v3.23.1
Prepaid Expenses and Other Current Assets (Tables)
12 Months Ended
Dec. 31, 2022
Prepaid Expenses and Other Current Assets [Abstract]  
Schedule of prepaid expenses
    December 31,  
    2022     2021  
Insurance (1)   $ 1,027,292     $ 1,937,693  
Research and development expense tax credit receivable     546,563       644,513  
Professional fees (1)     310,017       294,577  
Value-added tax receivable     48,774       24,411  
Taxes     25,634       25,634  
Other     -       49,755  
    $ 1,958,280     $ 2,976,583  

 

(1) In the previously filed Annual Report on Form 10-K for the year ended December 31, 2021, the Insurance line item above included $213,974 of expenses related to Oxford agreements for our CBR Pharma subsidiary. In the current year, those same expenses are grouped into the Professional fees grouping. As such, for comparative purposes, that amount has been moved from the Insurance grouping to the Professional fees grouping for the 2021 period.